INMED PHARMACEUTICALS INC. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9cf078b0-27b4-43c8-8e62-432ba5231a0d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-7.9M | 2022-07-01 – 2023-06-30 | evidence 0001213900-23-080842 |
| FY 2022 | $-18.6M | 2021-07-01 – 2022-06-30 | evidence 0001213900-22-058355 |
| FY 2021 | $-10.2M | 2020-07-01 – 2021-06-30 | evidence 0001213900-22-058355 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INMED PHARMACEUTICALS INC. — all facts · Revenue · Net Income